Delivery Order SPE2DB22D2206-SPE2DB24FHE02
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,972.30, is for the supply of the pharmaceutical product Tobi Podhaler 28 mg inhalation capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,186.01 firm fixed-price delivery order is for the supply of 4562300741 Tobi Podhaler 28 mg inhalation capsules. The contract has a completion date of September 26, 2023 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of pharmaceutical products and medical supplies. The award, valued at $12,239.13, is a firm fixed price delivery order for the Tobi Podhaler 28 mg inhalation capsules. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,745.92, is for the delivery of 4,562,406,339 units of TOBI PODHALER 28 MG INHALE CAP UD 56S, with an ultimate completion date of October 6, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen...
- This is a delivery order contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $41,392.19, is for the delivery of Tobi Podhaler 28 mg inhalation capsules. The contract has a firm fixed price pricing type and an ultimate completion date of September 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $18,676.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobi Podhaler 28 mg inhalation capsules and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBI PODHALER 28 MG INHALE CAP UD 56S, with an ultimate completion date of July 18, 2025 and a ceiling value of $61,724.87. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,816.31, is for the delivery of 4561740948 - TOBI PODHALER 28 MG INHALE CAP UD 56S, a pharmaceutical product. The award has an ultimate completion date of August 9, 2023, and was made on a firm fixed-price basis. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $21,416.84 fixed-price contract is for the supply of TOBI PODHALER 28 MG INHALE CAP UD 56S, a pharmaceutical product. The award has no set-aside designation and is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award, valued at $49,112.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order contract is for the supply of 4,566,026,535 units of the pharmaceutical product TOBI PODHALER 28 MG INHALE CAP UD 56S. The contract has a firm fixed price pricing type and an ultimate completion date of October 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHE02Delivery Order
This federal contract award is for the delivery of Tobi Podhaler 28 mg inhalation capsules in quantities of 56 to the Defense Logistics Agency (DLA). The $25,826.84 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 13, 2024. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.8k | 5/13/24 |